Shanghai Regenelead Therapies Co., Ltd.
Shanghai Regenelead Therapies Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Not yet recruiting | Early phase 1 | 2024-12-16 | NCT06735508 | |
| Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Not yet recruiting | Early phase 1 | 2023-12-05 | NCT06156267 |